A study on the effects on plasma insulin and glucose after a single meal replacement (InsuVital) with or without added Leucine in patients with T2DM

A study on the effects on plasma insulin and glucose after a single meal replacement (InsuVital) with or without added Leucine in patients with T2DM - Single dose InsuVital in T2DM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31143

Enrollment

Registered

2007-07-18

Start date

2007-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes glucose intolerance

Interventions

Treatments: The treatments will consist of a drink (shake) that will be freshly prepared prior to use. The composition of the 4 possible treatments is: 1. Carbohydrate / Fat / Vitamins & minerals 2.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adults >= 1 year oral anti-diabetic medication

Exclusion criteria

Exclusion criteria: insulin use significant diabetes complications

Design outcomes

Primary

Measure	Time frame
Main Parameters: Serum concentrations and AUC of glucose, insulin, and C-peptide.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)